EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 142 filers reported holding EPIZYME INC in Q4 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,010,000 | -14.0% | 686,966 | -32.7% | 0.00% | – |
| Q1 2022 | $1,175,000 | -26.3% | 1,021,113 | +60.2% | 0.00% | – |
| Q4 2021 | $1,594,000 | -50.5% | 637,481 | +1.3% | 0.00% | -100.0% |
| Q3 2021 | $3,221,000 | -39.1% | 629,078 | -1.2% | 0.00% | -50.0% |
| Q2 2021 | $5,289,000 | -3.1% | 636,398 | +1.5% | 0.00% | 0.0% |
| Q1 2021 | $5,459,000 | -17.3% | 626,692 | +3.1% | 0.00% | -33.3% |
| Q4 2020 | $6,600,000 | -8.4% | 607,660 | +0.6% | 0.00% | 0.0% |
| Q3 2020 | $7,208,000 | -17.1% | 604,142 | +11.6% | 0.00% | -25.0% |
| Q2 2020 | $8,696,000 | +16.7% | 541,416 | +12.7% | 0.00% | 0.0% |
| Q1 2020 | $7,452,000 | -35.4% | 480,454 | +2.5% | 0.00% | -33.3% |
| Q4 2019 | $11,537,000 | +141.7% | 468,945 | +1.3% | 0.01% | +100.0% |
| Q3 2019 | $4,773,000 | -17.2% | 462,714 | +0.7% | 0.00% | -25.0% |
| Q2 2019 | $5,765,000 | +21.7% | 459,308 | +20.1% | 0.00% | +33.3% |
| Q1 2019 | $4,737,000 | +131.9% | 382,296 | +15.3% | 0.00% | +50.0% |
| Q4 2018 | $2,043,000 | -30.1% | 331,550 | +20.3% | 0.00% | 0.0% |
| Q3 2018 | $2,922,000 | -21.8% | 275,576 | -0.0% | 0.00% | -33.3% |
| Q2 2018 | $3,736,000 | -20.3% | 275,704 | +4.4% | 0.00% | -25.0% |
| Q1 2018 | $4,687,000 | +51.9% | 264,011 | +7.4% | 0.00% | +100.0% |
| Q4 2017 | $3,085,000 | -25.4% | 245,756 | +13.2% | 0.00% | -50.0% |
| Q3 2017 | $4,138,000 | +79.8% | 217,168 | +42.5% | 0.00% | +100.0% |
| Q2 2017 | $2,302,000 | -17.0% | 152,447 | -5.7% | 0.00% | -33.3% |
| Q1 2017 | $2,773,000 | +77.6% | 161,646 | +25.3% | 0.00% | +50.0% |
| Q4 2016 | $1,561,000 | +29.4% | 128,996 | +5.3% | 0.00% | +100.0% |
| Q3 2016 | $1,206,000 | -7.5% | 122,528 | -3.8% | 0.00% | -50.0% |
| Q2 2016 | $1,304,000 | -14.0% | 127,302 | +1.8% | 0.00% | 0.0% |
| Q1 2016 | $1,516,000 | +18.1% | 125,052 | +56.1% | 0.00% | 0.0% |
| Q4 2015 | $1,284,000 | +28.5% | 80,104 | +3.1% | 0.00% | +100.0% |
| Q3 2015 | $999,000 | -43.3% | 77,668 | +5.9% | 0.00% | -50.0% |
| Q2 2015 | $1,761,000 | +143.6% | 73,334 | +90.7% | 0.00% | +100.0% |
| Q1 2015 | $723,000 | +4.8% | 38,455 | +5.2% | 0.00% | 0.0% |
| Q4 2014 | $690,000 | -9.8% | 36,539 | +29.5% | 0.00% | 0.0% |
| Q3 2014 | $765,000 | -11.1% | 28,211 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $861,000 | +116.9% | 27,655 | +58.7% | 0.00% | 0.0% |
| Q1 2014 | $397,000 | +48.7% | 17,431 | +35.9% | 0.00% | 0.0% |
| Q4 2013 | $267,000 | -47.7% | 12,826 | +3.5% | 0.00% | 0.0% |
| Q3 2013 | $511,000 | +44.4% | 12,394 | +4.9% | 0.00% | 0.0% |
| Q2 2013 | $354,000 | – | 11,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |